Loading ...

Autoantigen Vaccination in Human Type 1 DM

(

Orban / NDB12

)

ITN Protocol #:

ITN012AI

Branded Name:

Orban / NDB12

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Autoantigen Vaccination in Human Type 1 Newly Diagnosed Diabetes Mellitus

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

Study Personnel:

Protocol Chair

Tihamer Orban, MD

Work:

(617) 732-2400

Protocol Chair

Carol Soppe csoppe@immunetolerance.org

Work:

415-353-4879

Protocol Chair

Kristina Harris, PhD kharris@immunetolerance.org

Work:

240-235-6154

Protocol Chair

Nadia Tchao ntchao@immunetolerance.org

Work:

415-353-4414

Protocol Chair

Helena Diop dioph@niaid.nih.gov

Work:

301-402-7257

Admin Links

Shortcuts

ITN Documents

Links